Global Biologics Outsourcing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Biologics Outsourcing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Outsourcing is increasing as a percentage of the whole manufacturing capacity due to relatively more of new product manufacturing is outsourced and facilities with products that become generic are non-core and are being divested.
Biologics Outsourcing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biologics Outsourcing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Vaccine & Therapeutics Development and Blood & Blood Related Products Testing are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biologics Outsourcing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biologics Outsourcing key companies include Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private and Horizon Discovery Group, etc. Boehringer Ingelheim, Catalent, GenScript are top 3 players and held % share in total in 2022.
Biologics Outsourcing can be divided into Antibody, Recombinant, Protein and Vaccines, etc. Antibody is the mainstream product in the market, accounting for % share globally in 2022.
Biologics Outsourcing is widely used in various fields, such as Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy and Other, etc. Vaccine & Therapeutics Development provides greatest supports to the Biologics Outsourcing industry development. In 2022, global % share of Biologics Outsourcing went into Vaccine & Therapeutics Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Lonza
Abzena
Adimab
Segment by Type
Antibody
Recombinant
Protein
Vaccines
Others
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biologics Outsourcing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biologics Outsourcing introduction, etc. Biologics Outsourcing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biologics Outsourcing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Biologics Outsourcing report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biologics Outsourcing market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Vaccine & Therapeutics Development and Blood & Blood Related Products Testing are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biologics Outsourcing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Biologics Outsourcing key companies include Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private and Horizon Discovery Group, etc. Boehringer Ingelheim, Catalent, GenScript are top 3 players and held % share in total in 2022.
Biologics Outsourcing can be divided into Antibody, Recombinant, Protein and Vaccines, etc. Antibody is the mainstream product in the market, accounting for % share globally in 2022.
Biologics Outsourcing is widely used in various fields, such as Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy and Other, etc. Vaccine & Therapeutics Development provides greatest supports to the Biologics Outsourcing industry development. In 2022, global % share of Biologics Outsourcing went into Vaccine & Therapeutics Development filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Biologics Outsourcing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Boehringer Ingelheim
Catalent
GenScript
Innovent Biologics
Syngene
Shanghai Medicilon
GL Biochem Corporation
GVK Biosciences Private
Horizon Discovery Group
Selexis
Lonza
Abzena
Adimab
Segment by Type
Antibody
Recombinant
Protein
Vaccines
Others
Segment by Application
Vaccine & Therapeutics Development
Blood & Blood Related Products Testing
Cellular and Gene Therapy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biologics Outsourcing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biologics Outsourcing introduction, etc. Biologics Outsourcing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Biologics Outsourcing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.